BIOEN.E — Biotrend Cevre ve Enerji Yatirimlari AS Cashflow Statement
0.000.00%
- TRY10.33bn
- TRY13.86bn
- TRY2.23bn
- 34
- 27
- 73
- 38
Annual cashflow statement for Biotrend Cevre ve Enerji Yatirimlari AS, fiscal year end - December 31st, TRY millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 2.75 | 49.9 | 1.24 | 577 | 950 |
Depreciation | |||||
Non-Cash Items | 9.61 | 47.6 | 3.91 | 180 | -703 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 32.1 | -67 | -364 | -254 | 408 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 58.2 | 53 | -326 | 800 | 1,098 |
Capital Expenditures | -106 | -287 | -441 | -1,447 | -1,046 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 3.62 | -43.7 | 1.1 | -0.671 | 69.8 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -102 | -331 | -440 | -1,448 | -977 |
Financing Cash Flow Items | -9.49 | -10.9 | -23.7 | -86.1 | -219 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 52.9 | 361 | 835 | 229 | -19.9 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 8.76 | 83.5 | 69.1 | -419 | 102 |